While it’s not unusual for certain positions to turn over with a new administration, the number of senior-level FDA staffers ...

Roche’s reorganization of Spark Therapeutics is coming more into focus, with nearly 300 employees being let go by the end of ...

Sangamo, which has been having cash problems, will receive $18 million upfront in licensing fees for its AAV capsid that in ...

The FDA derives just under half of its yearly funding from pharma user fees, which help support its operations and fund ...

The FDA has asked for another well-controlled trial to establish the efficacy of reproxalap in dry eye disease.

The FDA approved Amgen ’s anti-CD19 therapy Uplizna Thursday for use in patients with IgG4-related disease. Uplizna is the ...

Advances Amgen’s Leadership in CD19 Directed, B-Cell Depletion Therapies for Serious Autoimmune Diseases Including NMOSD, IgG4-RD and gMG THOUSAND OAKS, Calif., April 3, 2025 /PRNewswire/ -- Amgen ...

HATFIELD, Pa.--(BUSINESS WIRE)--Biolyst Scientific, a leading provider of innovative solutions in the life sciences and clinical laboratory markets, is pleased to announce the appointment of Jay ...

Elutia management will also participate in 1x1 investor meetings. Institutional investors interested in scheduling a meeting may contact an LD Micro or Planet Microcap representative or email ...